is semaglutide off the fda shortage list Ozempic and Wegovy officially moved FDA's drug Semaglutide Shortage Ends: Compounded Versions

It is critical to never freeze Ozempic

Scenario 3: The Manufacturing Wedge The most underappreciated path to scale for Cost Plus Drugs runs through manufacturing rather than pharmacy

In clinical trials, it was highly effective and led to weight loss of up to 15% in some patients

Starting January 1, 2025, Kaiser CA base plans limited new weight-loss GLP-1 starts to members with Class III obesity (BMI 40 or higher), a more restrictive threshold than Wegovy's FDA-approved indication (BMI 30 or higher, or 27 or higher with a comorbidity)

your body can still regulate GH output to some degree (for example, if IGF-1 gets too high, feedback mechanisms can reduce further GH release)